Found 32 results
Filters: Author is Klein, Florian  [Clear All Filters]
Klein F, Mouquet H, Dosenovic P, Scheid JF, Scharf L, Nussenzweig MC.  2013.  Antibodies in HIV-1 vaccine development and therapy.. Science. 341(6151):1199-204.
Shingai M, Nishimura Y, Klein F, Mouquet H, Donau OK, Plishka R, Buckler-White A, Seaman M, Piatak M, Lifson JD et al..  2013.  Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia.. Nature. 503(7475):277-80.
Malbec M, Porrot F, Rua R, Horwitz J, Klein F, Halper-Stromberg A, Scheid JF, Eden C, Mouquet H, Nussenzweig MC et al..  2013.  Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission.. J Exp Med. 210(13):2813-21.
West AP, Scharf L, Horwitz J, Klein F, Nussenzweig MC, Bjorkman PJ.  2013.  Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues.. Proc Natl Acad Sci U S A. 110(26):10598-603.
Horwitz JA, Halper-Stromberg A, Mouquet H, Gitlin AD, Tretiakova A, Eisenreich TR, Malbec M, Gravemann S, Billerbeck E, Dorner M et al..  2013.  HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice.. Proc Natl Acad Sci U S A.
Gaebler C, Gruell H, Velinzon K, Scheid JF, Nussenzweig MC, Klein F.  2013.  Isolation of HIV-1-reactive antibodies using cell surface-expressed gp160Δc(BaL.).. J Immunol Methods. 397(1-2):47-54.
Hoot S, McGuire AT, Cohen KW, Strong RK, Hangartner L, Klein F, Diskin R, Scheid JF, Sather ND, Burton DR et al..  2013.  Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs.. PLoS Pathog. 9(1):e1003106.
Diskin R, Klein F, Horwitz JA, Halper-Stromberg A, Sather ND, Marcovecchio PM, Lee T, West AP, Gao H, Seaman MS et al..  2013.  Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies.. J Exp Med. 210(6):1235-49.
Klein F, Diskin R, Scheid JF, Gaebler C, Mouquet H, Georgiev IS, Pancera M, Zhou T, Incesu R-B, Fu BZhongzheng et al..  2013.  Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization.. Cell. 153(1):126-38.